Cover Image
市場調查報告書

全球人造器官市場

Artificial Organs

出版商 Global Industry Analysts, Inc. 商品編碼 236739
出版日期 內容資訊 英文 248 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球人造器官市場 Artificial Organs
出版日期: 2016年08月01日 內容資訊: 英文 248 Pages
簡介

本報告提供全球人造器官市場相關調查,彙整市場趨勢與各地區趨勢,2015∼2022年的預測,及加入此市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 人造器官引起醫療技術產業革命
    • 推動成長要素
    • 阻礙成長要素
    • 人造器官的龐大需求
    • 美國:人造器官市場上的壟斷勢力
    • 人造器官市場上人工腎臟佔莫大佔有率
    • 競爭模式
    • 技術進步促進成長
  • 各市場區隔分析
    • 人工心臟
    • 心室輔助裝置
    • 人工瓣膜
    • 人工腎臟
    • 人工肝臟
    • 人工胰臟 其他
  • 市場趨勢與課題
  • 人造器官影響市場的宏要素
    • 高齡化
    • ESRD及CKD患者人口的增加
    • 透析市場成長
    • 糖尿病發病率的上升 其他
  • 3D生物印刷
  • 技術進步
  • 產品概要
  • 生醫材料的簡介
  • 器官移植
  • 法律制度
  • 產品技術創新/引進
  • 近幾年的產業活動
  • 主要企業
    • Abbott Diabetes Care, Inc.
    • Abiomed, Inc.
    • 旭化成醫學株式會社
    • Baxter International, Inc.
    • F.Hoffmann-La Roche Ltd.
    • Fresenius Medical Care AG & Co. KGaA
    • HeartWare International, Inc.
    • Jarvik Heart, Inc.
    • Medtronic, Inc.
    • 日機裝株式會社
    • Nipro株式會社
    • SynCardia Systems, Inc.
    • Terumo Heart, Inc.
    • Thoratec Corp.
    • TORAY MEDICAL COMPANY LIMITED株式會社
    • Vital Therapies, Inc.
    • Xenios AG
  • 全球市場預測

第3章 市場

  • 美國
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1126

This report analyzes the worldwide markets for Artificial Organs in US$ Million by the following Product Segments: Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. The report provides separate comprehensive analytics for the US, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 48 companies including many key and niche players such as -

Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Artificial Organs
    • Artificial Heart
    • Artificial Kidneys
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Artificial Organs Revolutionize Medical Technology Industry
  • Growth Drivers
  • Growth Inhibitors
  • Artificial Organs Poised to Witness Significant Demand
  • The United States - A Dominant Force in the Artificial Organs Market
  • Artificial Kidneys Garner a Larger Pie in the Artificial Organs Market
  • Competitive Scenario
  • Technological Advancements Spearheading Growth

2. ANALYSIS BY SEGMENT

  • Artificial Heart
    • Table 1: Artificial Heart Transplants Worldwide (1969-2016): Percentage Share Breakdown of Number of Heart Transplants (includes corresponding Graph/Chart)
  • Medical Community Poised to Embrace Artificial Heart
  • Ventricular Assist Devices
    • Select Ventricular Assist Devices
  • Artificial Mechanical Heart Valves Come of Age
  • Artificial Kidney
  • Kidney Failure: A Major Concern
  • Artificial Kidney or Dialyzers Market
  • Major Initiatives in the Artificial Kidney Space
    • The Kidney Project
    • Current Status of the Kidney Project
  • Wearable Artificial Kidney Holds Promise to Transform Dialysis
  • Artificial Liver
  • Liver Support System to Provide Precious Time for Liver Transplantation
  • Liver Assist Devices Competitive Landscape
    • Select Liver Assist Devices
  • Artificial Pancreas
  • Artificial Pancreas Device System Market Presents Lucrative Opportunities
  • Market Overview
  • Scientific Community Inches towards Artificial Pancreas System
  • Competition and Key Developments in Artificial Pancreas Space
    • Artificial Pancreas Status in the US
  • Key Concerns

3. MARKET TRENDS AND ISSUES

  • The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease
    • Table 2: Prevalence of Heart Failure in Select Countries (includes corresponding Graph/Chart)
  • Artificial Pancreas System (APS) - The Future of Diabetes Care
  • Higher Development Costs and Lengthy Regulatory Process - Stumbling Blocks for Product Commercialization
  • Lack of Requisite Expertise - Hindering Implantation Process
  • Xenotransplantation - Other Alternative to Donor Organ Shortage
  • Artificial Organs from Cloned Animal Cells - A Promising Trend
  • Immunosuppressants Hold Promise in Artificial Organs Market
  • Move towards Smaller Implantable Devices
  • Barriers to Entry Significantly High in Dialyzers Market
  • Reuse of Dialyzers - A Major Issue in Dialysis Industry
  • Poor Reimbursement Environment Stymies Innovation
  • Product Recalls - A Major Blow to the Manufacturers
  • Higher Cost of Artificial Organs Hampers Broader Adoption
  • Major Issues Related to Artificial Organs
  • Financial
  • Legal
  • Ethical
  • Social

4. MACRO FACTORS IMPACTING THE ARTIFICIAL ORGANS MARKET

  • Aging Population: A Strong Growth Driver
  • Global Aging Population Statistics - Opportunity Indicators
    • Table 3: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart)
    • Table 4: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 5: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
    • Table 6: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart)
  • Expanding Pool of ESRD and CKD Patients - The Major Growth Driver for Kidney Dialysis Treatment
    • Table 7: Increasing Number of ESRD Patients Worldwide: 2014-2018 (includes corresponding Graph/Chart)
    • Table 8: ESRD Prevalence in Select Countries (2014): Number of ESRD Patients Per Million Population in EU-28, Japan, Taiwan, USA and Global (includes corresponding Graph/Chart)
  • Dialysis Market to Stage Steady Growth Amid Rising Prevalence of Kidney Diseases
    • Table 9: Global Population of ESRD Patients Undergoing Treatment by Type of Modality (2010, 2015E & 2020P): Percentage Breakdown of Patients Undergoing Dialysis Therapy, and Kidney Transplantation (includes corresponding Graph/Chart)
  • Developed Markets Maintain Lead, Emerging Markets to Dictate Momentum
    • Table 10: Worldwide Distribution of Dialysis Patients by Geographic Region (2015): Percentage Breakdown of Patient Population (includes corresponding Graph/Chart)
  • Rising Incidence of Diabetes: Opportunity Indicator for Artificial Pancreas
  • Growing Number of Type 1 Diabetes Cases
  • Global Diabetic Statistics - Opportunity Indicators
    • Table 11: Top 10 Countries for Number of Children with Type 1 Diabetes (2015) (includes corresponding Graph/Chart)
    • Table 12: Global Prevalence of Type 1 Diabetes in Children by Region (2015) (includes corresponding Graph/Chart)
  • A "Silent Killer" in Both Developed as well as Developing Nations
    • Table 13: Global Diabetes Mellitus Incidence among Ages 20-79 (2015 & 2040P): Prevalence (in Million) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
    • Table 14: Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2015 (includes corresponding Graph/Chart)
  • Dialysis Patient Population: An Opportunity Indicator for Artificial KIdneys
    • Table 15: Global Dialysis Patient Population by Geographic Region/Country (2014-2018): Breakdown of Patient Population for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
  • Distribution of Dialysis Patients by Modality
    • Table 16: Worldwide Dialysis Patient Population by Treatment Modality (2015): Percentage Breakdown of Hemodialysis (HD) Patients and Peritoneal Dialysis (PD) Patients for US, Japan, European Union, and Rest of World (includes corresponding Graph/Chart)
    • Table 17: Global Dialysis Patient Population Distribution by Modality for Select Countries (2015): Percentage Breakdown of Hemodialysis (HD) Patients and Peritoneal Dialysis (PD) Patients for US, China, Japan, Brazil, Mexico, Germany, India, Taiwan, Turkey, Thailand, Korea, Italy, France, Egypt, and Malaysia (includes corresponding Graph/Chart)

5. 3D BIOPRINTING - A GAME CHANGER FOR THE ARTIFICIAL ORGANS INDUSTRY

  • Application of 3D-Printing in the Medical Field
  • 3D Printing Revolutionizing the Medical Industry's Artificial Organ Development Segment
  • Issues to be Tackled
  • Sophisticated Software - A Key Element for 3D Printing
  • Bioprinters to Aid Medical Students
  • Bioprinters to Print Organs
  • Bioprinters for Printing Defective Organs for Surgeons to Practice On

6. TECHNOLOGICAL ADVANCEMENTS

  • New Artificial Pancreas with Sensor to Improve Insulin Management
  • Researchers at the University of California Come Up with an Artificial Kidney
  • Wearable Artificial Kidney Enters the US FDA's EAP Pipeline
  • New Artificial Pancreas System to Improve Diabetes Management
  • Production of 3D-like Artificial Organs in a Device that Works like a Cotton Candy Machine
  • Harvard Scientists Create Tissue Containing Blood Vessels
  • University of Washington Researchers Create Communicating Yeast Cells
  • ALung Technologies Develops Hemolung RAS Artificial Lung
  • The First Transplant of Small Sized Artificial Heart for Petite People Carried Out in California
  • Scientists Define Morphospace to Evaluate Viability of Artificial Organs

7. PRODUCT OVERVIEW

  • Categorization of Artificial Organs
    • External Artificial Organs
    • Internal or Implantable Artificial Devices
  • Artificial Heart
  • Total Artificial Heart (TAH)
  • Ventricle Assist Device (VAD)
    • Table 18: Distribution of Various Uses of VADs (includes corresponding Graph/Chart)
    • Right Ventricular Assist Systems (RVAS)
    • Left Ventricular Assist Systems (LVAS)
      • Categorization of LVAS
      • First Generation LVAS
      • Second Generation LVAS
      • Third Generation LVAS
      • Benefits of LVAS
    • Major Limitations and Complications of VADs
      • Infection
      • Internal Bleeding
      • Thrombus
      • Dependability
      • Cost
  • Natural Human Heart
  • Heart Diseases
    • Congenital Heart Disease
    • Congestive Heart Failure
  • Types of Heart Failure
    • Diastolic Heart Failure
    • Systolic Heart Failure
  • Artificial Heart - A Historical Perspective
  • Major Milestones in Artificial Heart Development
    • Jarvik-7
    • AbioCor Total Artificial Heart
    • CardioWest Temporary Total Artificial Heart
    • DuraHeart LVAS
    • HeartSaverVAD
    • VentrAssist Left Ventricular Assist Device
  • Artificial Kidney (Dialyzer)
  • Limitations of Artificial Kidney
  • Types of Dialysis
    • Hemodialysis
    • Peritoneal Dialysis
  • Advancements in Artificial Kidney Technology
  • Bioartificial Kidneys
    • Limitations of Bioartificial Kidneys
  • Hindrances to Develop Implantable Artificial Kidney
  • Artificial Kidneys - A Historical Perspective
  • Artificial Liver
  • Overdose of Drugs - A Leading Cause for Liver Damage
  • Categorization of Liver Devices
    • Mechanical Systems
      • Liver Dialysis Unit(tm)
    • Bio-Artificial Systems
      • Capillary Hollow Fiber Systems
      • Direct Perfusion Systems
      • Entrapment Based Systems
      • Major BAL Devices
      • Extracorporeal Liver Assist Device (ELAD)
      • Hybrid Artificial Liver Support System
  • History of Artificial Liver
    • Liver Assist Devices - Major Milestones
      • Nonbiological Method Introduction Time Line
      • Biological Method Introduction Time Line
  • Artificial Pancreas
  • Insulin Pumps - Historical Perspective
  • Bioartificial Pancreas
  • Nanotechnology in Artificial Pancreas
  • Artificial Lungs (Oxygenator)
  • About Human Lungs
  • Types of Artificial Lung
    • Intravenous Membrane Oxygenator
      • Hattler Respiratory Catheter
    • MC3 Pulmonary Assist Device
      • In-Series
      • In-Parallel
    • BioLung
  • Heart-Lung Bypass Machine
  • Role of Artificial Lungs during Surgery
    • Direct Contact Device
    • Indirect-Contact Type-Membrane Devices
  • Biorubber to be used in Artificial Lungs
  • History of Artificial Lungs
  • An Overview of Tissue Engineering

8. INTRODUCTION TO BIOMATERIALS

9. ORGAN TRANSPLANTATION

  • Europe and the United States Lead the Global Organ Transplants Market
    • Table 19: Global Organ Transplants Market (2014 & 2015): Number of Actual Deceased Organ Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 20: Global Organ Transplants Market (2014 & 2015): Number of Living Organ Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 21: Global Organ Transplants Market (2014): Number of Actual Donors After Cardiac Death Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 22: Global Heart Transplants Market (2014): Number of Transplants Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 23: Global Kidney Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 24: Global Kidney Transplants Market (2014): Number of Living Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 25: Global Liver Transplants Market (2014): Number of Deceased Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 26: Global Liver Transplants Market (2014): Number of Living Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 27: Global Pancreas Transplants Market (2014): Number of Transplants Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 28: Global Lung Transplants Market (2014): Number of Transplants Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
  • Sources of Donor Organs
    • Table 29: US Kidney Donations by Donor Type - Cadaveric and Living for Years 2010 through 2016 (includes corresponding Graph/Chart)
    • Table 30: US Liver Donations by Donor Type - Cadaveric and Living for Years 2010 through 2016 (includes corresponding Graph/Chart)
    • Table 31: US Heart Donations by Cadaveric Donor Type for Years 2010 through 2016 (includes corresponding Graph/Chart)
    • Table 32: US Lung Donations by Donor Type - Cadaveric and Living for Years 2010 through 2016 (includes corresponding Graph/Chart)
    • Table 33: US Pancreas Donations by Donor Type - Cadaveric and Living for Years 2010 through 2016 (includes corresponding Graph/Chart)
    • Table 34: European Organ Transplants Market (2014 & 2015): Number of Actual Deceased Organ Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
    • Table 35: European Organ Transplants Market (2014 & 2015): Number of Living Organ Donors Per Million Population (PMP) by Select Country (includes corresponding Graph/Chart)
  • Shortage of Donor Organs Restricts Transplantation Procedures
    • Table 36: Waiting List of Patient Registrations in the US by Organ Type: As of July 2016 (includes corresponding Graph/Chart)
  • Organ Rejection - A Major Barrier to Transplantation
  • Other Issues for Organ Transplantation
  • Illegal Organ Trafficking - A Risky Proposition
  • Ethical Concerns in Transplants
  • Bioethical Issues Hinder Organ Donation Process
  • Increasing Consent Rates - A Key Factor
  • Combined Organ Transplantation - Gaining Attention
  • Transplant Tourism - Creating Brighter Avenues

10. REGULATORY ENVIRONMENT

  • Regulatory Environment in the US
  • Regulatory Environment in Europe

11. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Medtronic Launches MiniMed(TM) 640G System
  • Pandorum Develops Artificial Human Liver Tissue

12. RECENT INDUSTRY ACTIVITY

  • Medtronic and HeartWare International Ink Merger Agreement
  • SynCardia Systems Inks an Agreement with Versa Capital Management
  • Vivonics Sells Artificial Lung Technology to Lung Biotechnology PBC
  • Insulet Corporation Enters into a Partnership and License Agreement with Mode AGC
  • Cellnovo Group Enters into a Partnership with TypeZero
  • St. Jude Medical Acquires Thoratec
  • Debiotech Collaborates with ARTORG Center to Develop Artificial Pancreas
  • DreaMed Diabetes Enters into an Agreement with Medtronic
  • Breethe Acquires Exclusive Rights from University of Maryland
  • SynCardia Systems Bags FDA Approval for SynCardia Temporary Total Artificial Heart's Destination Therapy Study
  • HeartWare International Bags Approval from Health Canada for HeartWare(r) Ventricular Assist System
  • Alung Technologies Announces Participation in the Pivotal Trial of ECCO2R Technology
  • ALung Technologies Announces EAP Designation for Hemolung RAS
  • Debiotech, AWAK and Neokidney Development Ink Join Venture Agreement
  • Carmat Implants Artificial Heart
  • Baxter International Acquires Gambro
  • Thoratec Acquires DuraHeart(r) II from Terumo
  • Sunshine Heart Enters into Collaboration with Minnetronix(R)
  • TandemDiabetes Care Enters into a Partnership with JDRF

13. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Diabetes Care, Inc. (USA)
  • Abiomed, Inc. (USA)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Baxter International, Inc. (USA)
  • F.Hoffmann-La Roche Ltd. (Switzerland)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • HeartWare International, Inc. (USA)
  • Jarvik Heart, Inc. (USA)
  • Medtronic, Inc. (USA)
  • Nikkiso Co., Ltd. (Japan)
  • Nipro Corporation (Japan)
  • SynCardia Systems, Inc. (USA)
  • Terumo Heart, Inc. (USA)
  • Thoratec Corp. (USA)
  • Toray Medical Co., Ltd. (Japan)
  • Vital Therapies, Inc. (USA)
  • Xenios AG (Germany)

14. GLOBAL MARKET PERSPECTIVE

    • Table 37: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 38: World Historic Review for Artificial Organs by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 39: World 14-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Dollar Sales for US and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 40: World Recent Past, Current & Future Analysis for Artificial Organs by Product Segment - Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas and Artificial Lungs Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 41: World Historic Review for Artificial Organs by Product Segment - Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas and Artificial Lungs Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 42: World 14-Year Perspective for Artificial Organs by Product Segment - Percentage Breakdown of Dollar Sales for Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas and Artificial Lungs Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 43: World Recent Past, Current & Future Analysis for Artificial Kidneys/Dialyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 44: World Historic Review for Artificial Kidneys/Dialyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 45: World 14-Year Perspective for Artificial Kidneys/Dialyzers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin American Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    • Table 46: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 47: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 48: World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • SynCardia's temporary Total Artificial Heart: The Only FDA Approved Artificial Heart
    • Ageing Demographics: A Major Driving Factor for Artificial Organs Market
    • Table 49: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Surging Diabetic Population Spurs Demand
    • Table 50: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
    • Table 51: The US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart)
    • Table 52: The US Diabetes Prevalence (in 000's) for 2010-2017P (includes corresponding Graph/Chart)
    • Table 53: Diabetes Prevalence in the US by Type: 2013 (includes corresponding Graph/Chart)
    • Table 54: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)
    • Artificial Pancreas System (APS): The Future of Diabetes Management
      • Artificial Pancreas Status in the US
    • Wearable Artificial Kidney Holds Promise to Transform Dialysis
    • Product Introduction
    • Strategic Corporate Developments
    • Focus on Select Key Players
  • B. Market Analytics
    • Table 55: The US Recent Past, Current & Future Analysis for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 56: The US Historic Review for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. REST OF WORLD

  • A. Market Analysis
    • Table 57: Dialysis Patient Population by Geographic Region/Country (2014-2018): Breakdown of Patient Population for Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
    • Table 58: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
    • Table 59: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
    • Table 60: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 61: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
    • Table 62: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 63: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
    • New Artificial Pancreas System to Improve Diabetes Management
    • EU-Supported Artificial Pancreas Project to Provide Competitive Edge to Europe
    • Product Introduction
    • Strategic Corporate Developments
    • Focus on Select Players
  • B. Market Analytics
    • Table 64: Rest of World Recent Past, Current & Future Analysis for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 65: Rest of World Historic Review for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top